Enable AccessibilityEnable Accessibility

Our Products in Australia

We are committed to bringing better health and a brighter future to patients by translating science into highly innovative medicines. Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

The following products are available from Takeda Pharmaceuticals Australia. For products available from Takeda Pharmaceuticals New Zealand please click here

Adcetris® (brentuximab vedotin)

Advate® (octocog alfa)

Adynovate® (rurioctocog alfa pegol)

Agrylin® (anagrelide hydrochloride)

Alunbrig® (brigatinib)

Ceprotin® (protein C, human)

Cuvitru® (normal immunoglobulin (human))

Entyvio® (vedolizumab)

Feiba NF® (Factor VIII inhibitor bypassing fraction)

Firazyr® (icatibant acetate)

Fosrenol® (lanthanum carbonate hydrate)

Hyqvia® (normal immunoglobulin infusion 10% (human) with vorhyaluronidase alfa)

Iclusig® (ponatinib hydrochloride)

Intuniv® (guanfacine hydrochloride)

Kiovig® (normal immunoglobulin (human) 10%)

Livtencity® (maribavir)

Mezavant® (mesalazine)

Mesalazine 1.2 Takeda®

Nesina® (alogliptin benzoate) and Nesina Met® (alogliptin benzoate / metformin hydrochloride)

Obizur® (recombinant porcine coagulation factor VIII, B-domain deleted, Susoctocog alfa (bhk))

Replagal® (agalsidase alfa ghu)

Revestive® (teduglutide)

Rixubis® (recombinant coagulation factor IX (rFIX), nonacog gamma (rch))

Somac® Injection (pantoprazole sodium)

Somac® (pantoprazole sodium sesquihydrate)

Somac® Heartburn Relief (pantoprazole sodium sesquihydrate)

Takhzyro® (Lanadelumab)

Vpriv® (velaglucerase alfa ghu)

Vyvanse® (lisdexamfetamine dimesilate)